Breaking News on Pharmaceutical Technology

Latest news headlines

Products

Suppliers

Hamburg calls for more FDA powers to ensure drug quality

14-Apr-2011 - FDA Commissioner Hamburg has asked for more supply chain security and quality control regulatory powers.

Univar expands white oils capacity, predicts pharma demand

14-Apr-2011 - Univar has announced plans to ramp up capacity for medicinal white oils, predicting that increased regulatory focus on supply chain integrity will drive drug industry demand.

Dr Reddy’s opens new Chirotech Technology Centre in UK

13-Apr-2011 - Dr Reddy’s Laboratories has moved its UK subsidiary, Chirotech, to a new purpose built lab facility at the Cambridge Science Park.

FDA spared in cuts as Reps aim to boost oversight

13-Apr-2011 - New powers and a budget increase, despite cuts to government spending, have been proposed to help the FDA monitor the global supply chain.

Nano Terra puts pen to paper in deal for Surface Logix

12-Apr-2011 - Nano Terra, a surface engineering and nanotechnology company based in Brighton Massachusetts, US, has struck a deal to acquire neighbouring drug developer, Surface Logix.

Amgen builds in Brazil with Bergamo buy and Hypermarcas deal

11-Apr-2011 - US drugmaker Amgen has acquired Brazilian manufacturer Bergamo in a bid to improve its access to ‘one of the fastest growing pharmaceutical markets in the world.”

FDA issues guidance on cross-contamination prevention

06-Apr-2011 - The FDA has released draft guidance on using separate facilities to prevent cross-contamination with non-penicillin beta lactam antibiotics.

News in brief

Glycotope Biotechnology begins Ab plant expansion

05-Apr-2011 - Germany-based Glycotope Biotechnology has stated adding new cleanrooms at its antibody production facility in Heidelberg.

BASF raises all API and excipient prices 10%

04-Apr-2011 - Chemicals supplier BASF has increased the price of all APIs and drug excipients by 10 per cent, citing higher costs

UK budget aims to attract & keep pharma manufacturers

24-Mar-2011 - The UK has drafted a budget to attract and keep business but there are still significant barriers to investment, warns the CIA.

Lonza wins manufacturing deals with Enobia and Athera

23-Mar-2011 - Switzerland-based Lonza has signed two new manufacturing deals with pharmaceutical firms that look set to improve capacity utilisation.

GSK joins UK Gov innovative manufacturing initiative

23-Mar-2011 - GSK is participating in a UK Government-backed innovative manufacturing initiative aimed at revitalising the sector.

UNCTAD to discuss fostering drug manufacturing in Africa

21-Mar-2011 - Next month the United Nations Conference on Trade and Development (UNCTAD) will organise a meeting to discuss ways of encouraging the production of pharmaceutical in Africa.

Cytovance secures $22.5m equity investment from Great Point Partners

16-Mar-2011 - Cytovance Biologics, the US-based biopharmaceutical contract manufacturer (CMO), has secured a growth equity investment from Connecticut, US-based private investors, Great Point Partners.

SOCMA and EFCG want foreign API sites to pay for US FDA inspections

15-Mar-2011 - SOCMA and the EFCG want the US FDA to make inspection of overseas API manufacturing sites mandatory, with the facilities paying for the costs themselves.

News in brief

IPCA gets MHRA OK for India API plant

10-Mar-2011 - API maker IPCA laboratories has received UK MHRA approval for its formulations and production unit in Indore, India.

Helsinn says cytotoxics plant will be up and running in 2012

08-Mar-2011 - Swiss pharmaceutical ingredient maker Helsinn says its new cytotoxic API production plant will be operational for laboratory-scale projects early next year.

Cadila JV to set up plant in Rwanda

07-Mar-2011 - CSM GlobalPharma has announced plans to invest $65m in a manufacturing facility in Kigali, Rwanda in collaboration with the Rwandan Development Board (RDB).

Mass-market pharma may build profit making supply chains

24-Feb-2011 - Mass-market drug manufacturers can turn a fixed cost into a service-providing revenue generator by investing in an agile supply chain, says PwC.

AstraZeneca to be “in Russia for Russia” with $150m plant

22-Feb-2011 - AstraZeneca has become the latest drug firm to invest in Russian manufacturing capcity with the announcment of plans for a $150m facility in the country’s Kaluga region.

News in brief

Azelis to buy S&D’s pharma ingredients biz

22-Feb-2011 - Belgian chemicals distributor Azelis has agreed to buy S&D Group citing its presence in key pharmaceutical ingredients markets as an important driver.

Endeavour rolls out thioamides targeting cancer R&D

21-Feb-2011 - UK-based Endeavour Specialty Chemicals has launched a range of thioamide intermediates, citing growing evidence of their potential role in development of new cancer treatments.

European Parliament votes yes on falsified medicines directive

17-Feb-2011 - The European Parliament has approved the falsified medicines directive and described it as a “huge step” in efforts to protect patients.

Canada lost more than 3,600 pharma jobs in H2 2010

16-Feb-2011 - Canada lost more than 3,600 pharmaceutical jobs in the second half of 2010 as domestic and export sales slowed.

Shamla announces deal to build Saudi facility

15-Feb-2011 - Shamla Pharmaceutical Industries has announced it will build a manufacturing facility in King Abdullah Economic City (KAEC), Saudi Arabia.

Sign up for your free newsletter